ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

KNSA Kiniksa Pharmaceuticals Ltd

18,675
0,125 (0,67%)
Zuletzt aktualisiert: 18:54:30
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Kiniksa Pharmaceuticals Ltd KNSA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,125 0,67% 18,675 18:54:30
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
18,49 18,2598 18,75 18,55
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
23.4.202413:30GLOBEKiniksa Pharmaceuticals Reports First Quarter 2024 Financial..
16.4.202422:01GLOBEKiniksa Pharmaceuticals to Report First Quarter 2024..
02.4.202413:30GLOBEKiniksa Pharmaceuticals Announces Development Indication for..
05.3.202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202423:29EDGAR2Form 144 - Report of proposed sale of securities
29.2.202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202413:35EDGAR2Form 8-K - Current report
28.2.202413:30GLOBEKiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year..
27.2.202423:06EDGAR2Form 144 - Report of proposed sale of securities
21.2.202422:01GLOBEKiniksa Pharmaceuticals to Report Fourth Quarter and..
14.2.202422:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202421:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
04.1.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202413:37EDGAR2Form 8-K - Current report
04.1.202413:30GLOBEKiniksa Pharmaceuticals Provides Corporate Update
03.1.202422:55EDGAR2Form 144 - Report of proposed sale of securities
02.1.202422:01GLOBEKiniksa Pharmaceuticals to Present at 42nd Annual J.P...
11.12.202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.12.202322:46EDGAR2Form 144 - Report of proposed sale of securities
02.11.202321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31.10.202312:35EDGAR2Form 8-K - Current report
31.10.202312:30GLOBEKiniksa Pharmaceuticals Reports Third Quarter 2023 Financial..
24.10.202322:01GLOBEKiniksa Pharmaceuticals to Report Third Quarter 2023..
07.9.202301:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202301:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202301:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202301:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202323:26EDGAR2Form 144 - Report of proposed sale of securities
18.8.202322:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10.8.202322:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01.8.202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27.7.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.7.202323:14EDGAR2Form 144 - Report of proposed sale of securities
25.7.202313:40EDGAR2Form 8-K - Current report
25.7.202313:30GLOBEKiniksa Pharmaceuticals Reports Second Quarter 2023..
17.7.202314:00GLOBEKiniksa Pharmaceuticals to Report Second Quarter 2023..
06.6.202322:01GLOBEKiniksa Pharmaceuticals to Present at Goldman Sachs 44th..
02.5.202313:30GLOBEKiniksa Pharmaceuticals Reports First Quarter 2023 Financial..
01.5.202322:01GLOBEKiniksa Pharmaceuticals to Report First Quarter 2023..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock